Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms
Targeting Neuroplasticity for Persistent Post-Concussive Cognitive Symptoms: A Trial of tDCS and Cognitive Training 3-12 Months Post-mTBI
University of Minnesota
30 participants
Mar 5, 2026
INTERVENTIONAL
Conditions
Summary
This project investigates an innovative combination of non-invasive neuromodulation (transcranial direct current stimulation - tDCS) and cognitive training as a novel treatment approach aimed at improving function in individuals suffering from persistent post-concussive syndrome (PPCS) following mild traumatic brain injury (mTBI).
Eligibility
Inclusion Criteria4
- Age 18-65
- Has sustained a single mTBI 3-12 months prior to enrollment
- Meets criteria for PPCS (assessed using the CP Screen)
- Has reliable access to a smartphone
Exclusion Criteria5
- Inability to provide informed consent or complete study procedures
- History of moderate/severe TBI
- Significant neurological or psychiatric disorders (other than PPCS-related symptoms like mild depression/anxiety)
- Substance dependence within the last six months
- Contraindications to tDCS (e.g., implanted metal, skin lesions on scalp)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
All participants will receive 10 sessions of cognitive training focused on executive functions, delivered over approximately 3 weeks. Cognitive training will be completed on a lab provided computer using PositScience BrainHQ or TaskFlow software. Concurrently, during each training session, participants will receive either active or sham tDCS. Stimulation will be delivered via saline-soaked sponge electrodes using the Soterix 1x1 miniCT TES device. The anode (active electrode) will be placed over the L-DLPFC (approximated by EEG coordinate F3) and the cathode (reference electrode) over the contralateral supraorbital area (Fp2). The active tDCS group will receive 2mA constant current for 20 minutes.
All participants will receive 10 sessions of cognitive training focused on executive functions, delivered over approximately 3 weeks. Cognitive training will be completed on a lab provided computer using PositScience BrainHQ or TaskFlow software. Concurrently, during each training session, participants will receive either active or sham tDCS. Stimulation will be delivered via saline-soaked sponge electrodes using the Soterix 1x1 miniCT TES device. The anode (active electrode) will be placed over the L-DLPFC (approximated by EEG coordinate F3) and the cathode (reference electrode) over the contralateral supraorbital area (Fp2). The sham tDCS group will receive a brief ramp up and ramp down of current at the beginning and end of the 20 minutes to mimic the sensation of active stimulation.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07246993